Precision Fluid Control for Food & Beverage Ingredient Additions
September 5, 2014
Fluid Metering, Inc.’s (FMI’s) Valveless Metering Pumps provide precision dispensing of additives for Food processing applications. Addition of vitamins, colors, flavors, fragrances, enzymes and preservatives are typical ingredients, which benefit from FMI’s valveless piston technology. Often in concentrated form, FMI pump’s precision of 0.5% ensures product consistency, while eliminating waste of expensive ingredients. FMI’s patented [...]
Abcam and Cell Marque sign global strategic marketing agreement for IVD IHC RabMAb® antibodies
September 4, 2014
Cambridge UK -- Abcam plc, a global leader in the manufacture and supply of innovative protein research tools and services, and Cell Marque Corporation, a provider of antibodies and reagents for diagnostic immunohistochemistry, announced today they have signed a global 10-year strategic marketing agreement for Abcam’s in vitro diagnostic (IVD) immunohistochemistry (IHC) RabMAb® primary antibody [...]
Agilent Technologies Introduces Tools for Next-Generation Genome Engineering
September 4, 2014
SANTA CLARA, Calif. -– Agilent Technologies Inc. (NYSE: A) today introduced SureGuide, the first in a new series of kits to advance genome editing and synthetic biology. The complete SureGuide workflow includes a SureGuide Cas9 Nuclease Kit, SureGuide gRNA Synthesis Kit and SureGuide gRNA Control Kit, all designed to work together for any lab interested [...]
ACEA Biosciences Introduces the xCELLigence® RTCA CardioECR System
September 4, 2014
San Diego, CA -- In response to the need for more predictive preclinical assays for cardiac liability, ACEA Biosciences, Inc. has introduced its next generation Cardio System, the xCELLigence RTCA CardioECR System. Building on the success of the impedance-only RTCA Cardio System, the new RTCA CardioECR system combines impedance and Multi Electrode Array (MEA) technology [...]
September 4, 2014
Cellectis (Alternext: ALCLS.PA) (Paris:ALCLS) a leader in the development of adoptive immunotherapies based on engineered allogeneic CART cells (UCART) today announces that it has closed the sale of its subsidiary Cellectis AB to Takara Bio Inc. The financials terms have not been disclosed. The Company now concentrates its activities in the field of oncology through [...]
Biocartis spins out life sciences multiplex platform Evalution into MyCartis
September 4, 2014
Mechelen (Belgium)-- Biocartis, an innovative molecular diagnostics company, announced today that it has combined its Swiss Evalution(1)(2) business unit with Belgian-based Pronota NV to jointly form MyCartis(2). MyCartis also completed an EUR 15 million equity round. Biocartis’ Evalution platform, previously known as DMAT, is designed for rapid and cost- effective detection of a broad range [...]
September 4, 2014
Victoria, BC -- GenoLogics today announced it has been selected by Illumina as the preferred laboratory information management system (LIMS) provider to support HiSeq X Ten sequencing system customers. Under the agreement, the companies are working closely to provide support for HiSeq X Ten whole-genome workflows and analysis pipelines, including those to be used inside [...]
September 4, 2014
Sunnyvale, CA -- Freeslate, Inc., the leading provider of high throughput research solutions for biopharmaceutical development, today announced the CM Protégé PharmD System will now support reaction screening and optimization. The CM Protégé PharmD System is an automated platform that supports a wide range of drug development applications, including high throughput polymorph, salt, co-crystal, and [...]
September 3, 2014
Fort Atkinson, Wis. -– Digi-Star LLC has formed a Near-infrared (NIR) partnership with Dinamica Generale S.p.A. to offer multiple NIR product solutions to North American producers. In addition to a portable NIR Moisture testing device, Digi-Star is now distributing two NIR feedstuff analyzing tools. Allowing farmers to gain near instantaneous dry matter, starch, crude protein [...]
September 3, 2014
CINCINNATI -- Meridian Bioscience Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced it has signed a new agreement with Premier, Inc. to offer the complete illumigene® molecular menu of tests to its members. Premier serves more than 3,000 U.S. hospitals and 110,000-plus other healthcare sites. This agreement offers each Premier healthcare facility the opportunity to implement rapid, [...]
